Surgery, Radiation and Proton Therapy for Lung Cancer Treatment at Penn

Christine Wilson, cancer survivor, shares her experiences from the Abramson Cancer Center’s 2012- Focus on Lung Cancer Conference. In this blog, she discusses new treatments in radiation and proton therapies for lung cancer patients. 


"At Penn, we care about the total patient experience,” says John Kucharczuk, MD. “ We know that for most people, the diagnosis of lung cancer is their first experience with this disease. As doctors, we need to recognize what that means to people, understand their anxiety level.”

Surgery for Lung Cancer

At Penn, the highest quality of surgical care for lung cancer encompasses understanding what it means to have this disease and undergo treatment. Penn has one of the largest divisions of thoracic surgery in the country, one that includes a dedicated surgical unit staffed with nurses who care only for patients who have undergone this kind of surgery.

Surgeons work as a team with experts from other disciplines to assure optimal care for every patient, and are leaders in developing new technologies and approaches that minimize the invasiveness of surgery, while maximizing the therapeutic effect. These include innovative approaches to lung sparing surgery, robotic platforms and the use of photosensitizers to improve local control of tumors.

Skill and technology are critical, but underlying the Penn program is an active commitment to preserving quality of life for patients. To Dr. Kucharczuk and his team, that involves engaging with each patient to understand what quality of life means to that person, and working to tailor the treatment to the individual.

Radiation and Proton Therapy for Lung Cancer

"Lung cancer treatment is a 'team sport.' We see ourselves as a group of physicians who have the privilege of caring for you. Effective treatment is truly a partnership with our patients." Ramesh Rengan, MD.

For many lung cancer patients, radiation therapy is an important part of their treatment. Penn offers a number of options to patients with most kinds and stages of lung cancer. These include:

• Conventional radiation therapy utilizing 3-D imaging and IMRT
• Protons
• Stereotactic body radiation

Charles Simone, MD, emphasized that there are two major components in delivering effective radiation therapy to lung cancer patients.

• Where is the cancer? This means locating the tumor as precisely as possible. Penn is one of the few centers that has integrated PET scanning and metabolic evaluation of tumors into this process.
• How do we target the cancer? This means getting as much of the radiation dose to the tumor while sparing normal tissue.

The exact type of radiation used depends on the patient--the kind and extent of the cancer, and the overall health or other conditions that might exist. Newer options, such as stereotactic body radiation are making it possible to treat older, sicker or more advanced patients.

Proton therapy is another option for patients with locally advanced lung cancers, the most common diagnosis. Penn is one of only eight centers in the United States that offers proton therapy--a technique that allows more precise, targeted delivery of radiation to the tumor. Protons have the potential to reduce side effects from therapy while being equally effective in treating the cancer.

See all the presentations from the Focus On Lung Cancer Conference here.